Immunai, BCM developing first-in-human cell therapy for neuroblastoma
Immunai CEO Noam Solomon: “We keep growing Immunai and strengthening the platform.”
Stay updated with breaking news from Functional Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunai CEO Noam Solomon: “We keep growing Immunai and strengthening the platform.”
Scientists in the United Kingdom and the United States have created synthetic human-like embryos without the need for eggs or sperm. While the embryo
Scientists at the California Institute of Technology and the University of Cambridge in Britain have used stem cells to create what they call a "synthetic human embryo." The scientists involved promise they will use the technology for research purposes and not to produce transhuman nightmares beyond our comprehension.
Scientists at the California Institute of Technology and the University of Cambridge in Britain have used stem cells to create what they call a "synthetic human embryo." The scientists involved promise they will use the technology for research purposes and not to produce transhuman nightmares beyond our comprehension.
Scientists in the United Kingdom and the United States have created synthetic human-like embryos without the need for eggs or sperm. While the embryo does not have a brain or heartbeat, scientists are hopeful that it will shed light on the cause of miscarriages and genetic diseases.